Harn-Shen Chen
-
- Diabetes Management and Research 6
- Diabetes Treatment and Management 6
- Thyroid Disorders and Treatments 4
- Diabetes, Cardiovascular Risks, and Lipoproteins 3
- Thyroid Cancer Diagnosis and Treatment 3
-
- Pancreatic function and diabetes 2
-
- Diabetes and associated disorders 3
-
- Metabolism, Diabetes, and Cancer 2
- Journals
- Diabetes Research and Clinical Practice (3 papers)ULTRASONOGRAPHY (1 paper)PLoS ONE (1 paper)
- Partner nations
- Taiwan
In The Last Decade
Harn-Shen Chen
19 papers receiving 277 citations
Peers
Comparison fields: 5 of 58
- Endocrinology, Diabetes and Metabolism 224
- Surgery 92
- Genetics 44
- Nephrology 10
- Aging 2
Countries citing papers authored by Harn-Shen Chen
This map shows the geographic impact of Harn-Shen Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harn-Shen Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harn-Shen Chen more than expected).
Fields of papers citing papers by Harn-Shen Chen
This network shows the impact of papers produced by Harn-Shen Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harn-Shen Chen. The network helps show where Harn-Shen Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Harn-Shen Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 11 | |
| 8 | 2022 | 7 | |
| 9 | 2022 | 7 | |
| 10 | 2022 | 16 | |
| 11 | 2022 | 1 | |
| 12 | 2022 | 17 | |
| 13 | 2022 | 12 | |
| 14 | 2021 | 1 | |
| 15 | 2020 | 37 | |
| 16 | 2020 | 4 | |
| 17 | 2016 | 5 | |
| 18 | Prognostic factors of mortality among patients with severe hyperglycemia. | 2015 | 9 |
| 19 | 2008 | 129 | |
| 20 | 1998 | 16 |
About Harn-Shen Chen
Harn-Shen Chen is a scholar working on Endocrinology, Diabetes and Metabolism, Internal Medicine and Pathology and Forensic Medicine, having authored 22 papers that have together received 283 indexed citations. Recurring topics across this work include Diabetes Management and Research (6 papers), Diabetes Treatment and Management (6 papers), Thyroid Disorders and Treatments (4 papers), Diabetes and associated disorders (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Thyroid Cancer Diagnosis and Treatment (3 papers), Pancreatic function and diabetes (2 papers) and Metabolism, Diabetes, and Cancer (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (224 citations), Surgery (92 citations) and Genetics (44 citations). Harn-Shen Chen has collaborated with scholars based in Taiwan. Frequent co-authors include Tzu-En Wu, Hong-Da Lin, Tjin‐Shing Jap, L. Hsiao, Jen‐Fan Hang, Yu‐Cheng Lee, Yuwen Su, An‐Hang Yang, Chii‐Min Hwu and Ching Fai Kwok. Their work appears in journals such as Diabetes Research and Clinical Practice, ULTRASONOGRAPHY, PLoS ONE, Journal of Clinical Medicine and BMC Pregnancy and Childbirth.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.